Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
AstraZeneca
Cerilliant
McKinsey
Mallinckrodt
Teva
Merck
Chubb
Dow

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019014

« Back to Dashboard

NDA 019014 describes BENYLIN, which is a drug marketed by Parke Davis and is included in two NDAs. Additional details are available on the BENYLIN profile page.

The generic ingredient in BENYLIN is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
Summary for 019014
Tradename:BENYLIN
Applicant:Parke Davis
Ingredient:diphenhydramine hydrochloride; pseudoephedrine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;ORALStrength12.5MG/5ML;30MG/5ML
Approval Date:Jun 11, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Cipla
US Army
Citi
Baxter
Covington
Chinese Patent Office
US Department of Justice
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.